Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (22.499)

21

Mucoadhesive polymers : Design of S-protected thiolated cyclodextrin-based hydrogels

enthalten in: International journal of pharmaceutics | 2024

von Fürst, A. | Kali, G. | Dizdarević, A. | +2

22

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

enthalten in: Expert review of anti-infective therapy | 2024

von Hsu, C. | Hsu, W. | Shiau, B. | +6

23

Disappearing Polymorphs Reappear in the Mill: The Case of Ritonavir

enthalten in: chemRxiv.org | 2024

von Sacchi, P. | Wright, S. | Neoptolemou, P. | +6

24

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

25

Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era : a systematic review

enthalten in: Expert opinion on drug metabolism & toxicology | 2024

von Conti, V. | Bertini, N. | Ricciardi, R. | +8

26

SARS-CoV-2 Mpro oligomerization as a potential target for therapy

enthalten in: International journal of biological macromolecules | 2024

von Lis, K. | Plewka, J. | Menezes, F. | +10

27

The interplay of poorly soluble drugs in dissolution from amorphous solid dispersions

enthalten in: International journal of pharmaceutics: X | 2024

von Kokott, M. | Breitkreutz, J. | Wiedey, R.

28

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2024

von Hammond, J. | Fountaine, R. | Yunis, C. | +10

29

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease : A PHASE 2/3, INTERVENTIONAL SAFETY, PHARMACOKINETICS, AND EFFICACY, OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332 (NIRMATRELVIR)/RITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID-19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE

enthalten in: ClinicalTrials.gov | 2024

30

A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women : A PHASE I, MULTIPLE DOSE, OPEN-LABEL PHARMACOKINETIC STUDY OF NIRMATRELVIR/RITONAVIR IN HEALTHY LACTATING WOMEN

enthalten in: ClinicalTrials.gov | 2024